Non‐coding <i>FLT3</i> Mutation is Associated with Lower Galectin Levels in Breast Cancer Patients
Avery Funkhouser(National Institutes of Health), Anna V. Blenda(University of South Carolina), Jane L. Goodwin(University of South Carolina), Julie Martin(Prisma Health), Alec Strigenz(Prisma Health), William J. Edenfield(Prisma Health), Bailey B. Blair(University of South Carolina), Christopher Ronald Funk(Emory University)
Cited by 0
Related Papers
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
|Journal for ImmunoTherapy of Cancer|2020|117
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer
|Cancers|2021|36
Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis
|Current Issues in Molecular Biology|2021|33